·Category 1 new drug ·The world's first 99.9% pure trans-isomer glycyrrhizinate ·Winner of the "China Patent Gold Award" ·The first and only drug in China approved for the indication of acute drug-induced liver injury ·Served over 35 million patients cumulatively

*For contraindications and adverse reactions, please see the package insert

·First generic to be marketed in China, a mainstream anti-HBV drug ·Achieved independent R&D and industrialization in China of a mainstream international anti-hepatitis B virus drug, addressing the significant public issue of difficult and expensive access to medication for domestic patients ·In 2016, it became the only Chinese product selected as one of the "Top 10 Global Antiviral Drugs" and in the same year received the "Most Clinically Substitutable Generic Drug" award from institutions including the Chinese Academy of Medical Sciences ·Since its launch, it has cumulatively treated approximately 3.5 million chronic hepatitis B patients

*For contraindications and adverse reactions, please see the package insert

·An enteric-coated capsule of a lipid complex composed of α-diammonium glycyrrhizinate and phosphatidylcholine, which greatly improves the bioavailability of α-diammonium glycyrrhizinate (4.87-fold) ·Has a dual synergistic effect of anti-inflammation and repairing hepatocyte membranes ·Recommended as a fundamental drug for the treatment of liver inflammation by dozens of authoritative domestic hepatology-related guidelines and consensuses, including the "Guidelines for the Diagnosis and Treatment of Primary Hepatic Cancer" and the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B"

*For contraindications and adverse reactions, please see the package insert

· First generic oral small-molecule thrombopoietin receptor agonist (TPO-RA) to be marketed in China ·The only TPO-RA in China with dual indications for both hepatology and hematology ·Oral administration avoids the potential risks associated with platelet transfusion ·No dose adjustment is required for use in special populations, with good adherence

*For contraindications and adverse reactions, please see the package insert